Jim Simons
ENZN

Jim Simons’s ENZON PHARMACEUTICALS INC ENZN Stock Holding History

Jim Simons’s Portfolio ENZN Stock Details ENZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-3,143,585
Closed -$1.48M – 3691
2016
Q1 		$1.48M Sell
3,143,585
-358,000
-10% -$175K ﹤0.01% 2393
2015
Q4 		$2.39M Sell
3,501,585
-38,499
-1% -$30.5K 0.01% 1999
2015
Q3 		$3.43M Sell
3,540,084
-74,825
-2% -$92.1K 0.01% 1646
2015
Q2 		$4.34M Buy
3,614,909
+1,429,002
+65% +$1.82M 0.01% 1530
2015
Q1 		$2.32M Buy
2,185,907
+379,223
+21% +$392K ﹤0.01% 1854
2014
Q4 		$1.97M Buy
1,806,684
+233,300
+15% +$245K ﹤0.01% 1800
2014
Q3 		$1.7M Buy
1,573,384
+455,200
+41% +$562K ﹤0.01% 1764
2014
Q2 		$1.16M Buy
1,118,184
+146,200
+15% +$139K ﹤0.01% 1986
2014
Q1 		$1M Buy
971,984
+206,700
+27% +$213K ﹤0.01% 2079
2013
Q4 		$888K Sell
765,284
-54,700
-7% -$84.2K ﹤0.01% 2129
2013
Q3 		$1.38M Sell
819,984
-90,324
-10% -$167K ﹤0.01% 1855
2013
Q2 		$1.82M Buy
+910,308
New +$2.67M ﹤0.01% 1633

Other funds holding ENZN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return
MCM
Monarch Capital Management Fort Wayne, Indiana $436M AUM 26.61% 1-Year Est. Return
CFA
CT Financial Advisors Chadds Ford, Pennsylvania $162M AUM 9.58% 1-Year Est. Return

Jim Simons's ENZN Position: Q2 2016 in Review

Jim Simons sold out of ENZON PHARMACEUTICALS INC (ENZN) in Q2 2016, closing a stake of 3,143,585 shares — an estimated $1.48M sold.

Jim Simons first reported a position in ENZN in Q2 2013 and held it in 12 quarters. The position peaked at $4.34M in Q2 2015. 10 funds tracked by Wall St. Rank hold ENZN as of Q2 2016.

  • Jim Simons reported no remaining ENZON PHARMACEUTICALS INC position as of Q2 2016 after selling out during the quarter.
  • Jim Simons sold 3,143,585 ENZON PHARMACEUTICALS INC shares in Q2 2016, an estimated $1.48M.
  • Jim Simons first reported a position in ENZON PHARMACEUTICALS INC in Q2 2013 and held it in 12 quarters.
  • Jim Simons's ENZON PHARMACEUTICALS INC position peaked at $4.34M in Q2 2015.
  • 10 funds tracked by Wall St. Rank held ENZON PHARMACEUTICALS INC as of Q2 2016.

Based on Renaissance Technologies's 13F filing for Q2 2016, filed 12 Aug 2016.